Symbiox Investment & Trading Co Ltd has announced its unaudited financial results for the third quarter of fiscal year 2026, following the board meeting held on February 7, 2026. The company reported revenue from operations of ₹8.60 lakh and net profit of ₹1.23 lakh for the quarter ended December 31, 2025.

Board Meeting Outcome and Approval

The board meeting was successfully conducted on Saturday, February 7, 2026, at the company's registered office in Kolkata, commencing at 2:30 P.M. and concluding at 3:20 P.M. The directors approved the unaudited financial results pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with the Auditor's Limited Review Report.

Q3FY26 Financial Performance

The company's financial performance for the quarter ended December 31, 2025, showed mixed results compared to previous periods. Revenue from operations declined significantly to ₹8.60 lakh from ₹23.15 lakh in the previous quarter and ₹45.47 lakh in the corresponding quarter of the previous year.

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, the company reported total income of ₹77.79 lakh compared to ₹151.90 lakh in the corresponding period of the previous year. Net profit for the nine-month period stood at ₹14.01 lakh, significantly lower than ₹49.13 lakh achieved in the previous year.

Regulatory Compliance and Auditor Review

The financial results were reviewed by the Audit Committee and received a clean auditor's report from S S R V & Associates, Chartered Accountants. The independent auditors confirmed that the unaudited financial results comply with applicable accounting standards and SEBI regulations, with no material misstatements identified.

Stock Exchange Notifications

Symbiox Investment & Trading Co Ltd has formally notified all relevant stock exchanges about the board meeting outcome and financial results. The company maintains listings on multiple exchanges with trading symbols BSE: 539278, CSE: 029461, and MSE: SYMBIOX. The notifications were signed by Khushboo Pitti, Company Secretary and Compliance Officer, ensuring full regulatory compliance.

Symbiox Investment & Trading Co Ltd , a Kolkata-based investment and trading firm, has reported a significant improvement in its financial performance for the first quarter. The company's board of directors approved the unaudited financial results in a meeting held on August 6.

Financial Highlights

• Profit Surge: The company reported a profit of ₹6.69 lakh for the quarter, marking a substantial increase from ₹0.56 lakh in the same quarter last year. This represents a year-over-year growth of approximately 1095%.

• Revenue Growth: Revenue from operations increased to ₹45.81 lakh from ₹31.23 lakh year-over-year, showing a growth of about 46.7%.

• Total Income: The company's total income reached ₹46.00 lakh versus ₹31.23 lakh in the previous year's quarter, indicating a rise of 47.3%.

• Earnings Per Share: Basic earnings per share improved to ₹0.02 from ₹0.00 in the corresponding quarter last year.

Quarterly Performance Comparison

The following table summarizes the key financial metrics for the current quarter compared to the previous quarter and the same quarter last year:

Turnaround from Previous Quarter

The current quarter results represent a significant turnaround from the previous quarter, when the company had posted a loss of ₹29.94 lakh. This improvement indicates a positive shift in the company's operational efficiency and market performance.

Management's Actions

The board meeting, which commenced at 2:00 PM and concluded at 3:15 PM on August 6, also adopted the auditor's limited review report. The statutory auditors, SS RV & Associates, Chartered Accountants, conducted a review of the financial results in accordance with the Standard on Review Engagements (SRE) 2410.

Auditor's Review

The independent auditors' review report stated that nothing has come to their attention that causes them to believe that the financial results were not prepared in accordance with applicable accounting standards and other recognized accounting practices and policies.

Symbiox Investment & Trading Co Ltd's strong start to the quarter reflects positively on its business strategies and market positioning. Investors and stakeholders will likely keep a close watch on the company's performance in the coming quarters to see if this growth trajectory can be maintained.